Literature DB >> 8922085

Primary prevention in a high-risk group: smoking habits in adolescents with homozygous alpha-1-antitrypsin deficiency (ATD).

T Thelin1, T Sveger, T F McNeil.   

Abstract

The serious form of alpha-1-antitrypsin deficiency (ATD) Pi ZZ strongly predisposes the individual for pulmonary emphysema and premature death in adulthood, especially if exposed to tobacco smoking. General screening of all new-born children was conducted in Sweden during 1972-1974, the major purpose being to reduce exposure of the child to parental smoking while growing up and to prevent the child from starting to smoke. Sixty-one children with ATD neonatally identified through mass-screening, and their families, have been compared with a demographically matched control group regarding smoking habits, as studied through interviews and questionnaires on two occasions. When the children were 5-7 years old, the smoking rates among parents of the ATD children and especially among the ATD fathers exceeded smoking rates for controls. Thirteen years later no differences in parental smoking were found between the groups. At 18-20 years of age the ATD children reported smoking significantly less than the control children (p < 0.05). From the perspective of prevention, the goal of the neonatal screening to reduce the smoking rates among the parents of the ATD children was not attained, while it was achieved among the ATD children. The results indicate that a screening program with early detection of ATD effectively prevents adolescent children from starting to smoke. From ethical, medical and psychological points of view, a voluntary screening program for ATD in pre-adolescence is recommended.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8922085     DOI: 10.1111/j.1651-2227.1996.tb18230.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  10 in total

Review 1.  Direct-to-consumer personalized genomic testing.

Authors:  Cinnamon S Bloss; Burcu F Darst; Eric J Topol; Nicholas J Schork
Journal:  Hum Mol Genet       Date:  2011-08-09       Impact factor: 6.150

2.  Respiratory health equality in the United States. The American thoracic society perspective.

Authors:  Juan C Celedón; Jesse Roman; Dean E Schraufnagel; Alvin Thomas; Jonathan Samet
Journal:  Ann Am Thorac Soc       Date:  2014-05

3.  Characteristics of Chronic Obstructive Pulmonary Disease (COPD) Patients Reporting Alpha-1 Antitrypsin Deficiency in the WebMD Lung Health Check Database.

Authors:  Tyler McGrady; David M Mannino; Elisha Malanga; Byron M Thomashow; John Walsh; Robert A Sandhaus; James K Stoller
Journal:  Chronic Obstr Pulm Dis       Date:  2015-04-15

4.  Alpha-1-Antitrypsin Deficiency: An Important Cause of Pediatric Liver Disease.

Authors:  Amy Feldman; Ronald J Sokol
Journal:  Lung Health Prof Mag       Date:  2013

5.  Appropriateness of newborn screening for α1-antitrypsin deficiency.

Authors:  Jeffrey Teckman; Erin Pardee; R Rodney Howell; David Mannino; Richard R Sharp; Mark Brantly; Adam Wanner; Jamie Lamson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-02       Impact factor: 2.839

Review 6.  Advances in managing COPD related to α1 -antitrypsin deficiency: An under-recognized genetic disorder.

Authors:  Timothy J Craig; Maria Paula Henao
Journal:  Allergy       Date:  2018-07-26       Impact factor: 13.146

7.  Alpha1-Antitrypsin Deficiency: Transition of Care for the Child With AAT Deficiency into Adulthood.

Authors:  Henry C Lin; Nagraj Kasi; J Antonio Quiros
Journal:  Curr Pediatr Rev       Date:  2019

Review 8.  Diagnosis and treatment of lung disease associated with alpha one-antitrypsin deficiency: A position statement from the Thoracic Society of Australia and New Zealand.

Authors:  Jack Dummer; Claudia C Dobler; Mark Holmes; Daniel Chambers; Ian A Yang; Lianne Parkin; Sheree Smith; Peter Wark; Anouk Dev; Sandra Hodge; Eli Dabscheck; Julian Gooi; Sameh Samuel; Steven Knowles; Anne E Holland
Journal:  Respirology       Date:  2020-02-06       Impact factor: 6.424

9.  The Clinical Course of Severe Alpha-1-Antitrypsin Deficiency in Patients Identified by Screening.

Authors:  Adriana-Maria Hiller; Eeva Piitulainen; Hanan Tanash
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-01-05

Review 10.  Alpha-1 antitrypsin deficiency: outstanding questions and future directions.

Authors:  María Torres-Durán; José Luis Lopez-Campos; Miriam Barrecheguren; Marc Miravitlles; Beatriz Martinez-Delgado; Silvia Castillo; Amparo Escribano; Adolfo Baloira; María Mercedes Navarro-Garcia; Daniel Pellicer; Lucía Bañuls; María Magallón; Francisco Casas; Francisco Dasí
Journal:  Orphanet J Rare Dis       Date:  2018-07-11       Impact factor: 4.123

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.